Source link : https://www.newshealth.biz/health-news/potential-for-long-term-survival-with-icis-in-melanoma/
TOPLINE: About 90% of patients with advanced melanoma who had a complete response to first-line immune checkpoint inhibitors survived more than 3 years, with survival curves plateauing over time, a large population-based analysis showed. This finding suggests the potential for long-term survival in this population of responders. METHODOLOGY: Previous clinical trial research exploring survival trends […]
Author : News Health
Publish date : 2024-08-27 07:52:08
Copyright for syndicated content belongs to the linked Source.
Categories